Clinical Trial Update: Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing nintedanib with placebo for radiation-induced pneumonitis in patients with non-small cell lung cancer undergoing chemoradiation; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Radiation-induced Pneumonitis

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lung Non-Squamous Non-Small Cell Carcinoma, Radiation-Induced Pneumonitis | Phase 2 | Status: TERMINATED | Results posted: 2020-04-06